|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
 |
|
|
Jonathan J. Fleming
- Managing General Partner Boston, MA
Jonathan Fleming is the Managing General Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, with offices in Boston and Connecticut. - more
|
 |
 |
|
|
Matthew A. Gibbs
- General Partner Boston, MA
Mr. Gibbs joined Oxford Bioscience Partners in 1997. He has 15 years of investing experience in the lifescience and technology venture industry. - more
|
 |
 |
|
|
Ellen S. Baron, Ph.D.
- Partner Boston, MA
Dr. Baron joined Oxford Bioscience Partners in 2003 and is currently is a Partner at the firm. - more
|
 |
 |
|
|
Omar Amirana, M.D.
- Partner Boston, MA
Dr. Amirana is a Partner at Oxford focused on healthcare technology investing. He joined Oxford in 2005 with 15 years of industry-related experience in both large and small companies. - more
|
 |
 |
|
|
Edmund M. Olivier
- Senior General Partner Costa Mesa, CA
Mr. Olivier has a profitable record of financing and managing biotechnology and healthcare investments over the last 20 years. He has been Chairman, President or Director of more than twenty life science companies in the U.S., Europe and Asia. - more
|
 |
 |
|
|
Cornelius T. Ryan
- Founding General Partner Westport, CT
Cornelius T. Ryan (Neil) co-founded Oxford Partners in 1981 and is the only partner involved in all previous Oxford funds. Neil is a Special Limited Founding Partner of Oxford Bioscience III and a General Partner of Oxford Bioscience I and II. - more
|
 |
 |
|
|
Alan G. Walton, Ph.D., D.Sc.
- Senior General Partner Westport, CT
Alan G. Walton, Ph.D., D.Sc. has served as a director of our company since March 2003. Dr. Walton joined Oxford Partners as a General Partner in 1987. - more
|
 |
| |
|
|
|
|
|
|
|
 |
| |
 |
|
|
Manuel A. Navia, Ph.D.
- Executive-in-Residence Boston, MA
Dr. Navia is currently an Executive-in-Residence at Oxford Bioscience Partners. He is also a consultant for a number of pharmaceutical companies in the Boston area. - more
|
 |
 |
|
|
David Poorvin, Ph.D.
- Executive-in-Residence Boston, MA
Dr. Poorvin has over 35 years of experience in the pharmaceutical and biotech industry. - more
|
 |
 |
|
|
Axel Unterbeck, Ph.D.
- Executive-in-Residence Boston, MA
Dr. Axel Unterbeck joined Oxford Bioscience Partners in 2005. Prior to joining Oxford, Dr. Unterbeck was President, Chief Scientific Officer, and Co-Founder at Memory Pharmaceuticals, Corp which achieved its initial public offering in April of 2004, NASDAQ: MEMY. - more
|
 |
| |
|
|
|
|
|
|
|
|
|
|
|